Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Revenue by Product

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015
Natural Health Supplement	598.39K
Natural Health Supplement Growth	-20.18%
Consulting	45.00K
Freight	31.65K
Freight Growth	-51.02%
Manufacturing	27.04K
Manufacturing Growth	-49.62%

Revenue by Geography

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015
Asia	435.72K
Asia Growth	-29.29%
Canada	138.34K
Canada Growth	22.61%
United States	128.01K
United States Growth	-7.82%